Sost Deficiency does not Alter Bone’s Lacunar or Vascular Porosity in Mice
SCLEROSTIN (Sost) is expressed predominantly in osteocytes acting as a negative regulator of bone formation. In humans, mutations in the SOST gene lead to skeletal overgrowth and increased bone mineral density, suggesting that SCLEROSTIN is a key regulator of bone mass. The function of SCLEROSTIN as...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-09-01
|
Series: | Frontiers in Materials |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fmats.2017.00027/full |